TLS – UBS rates the stock as Neutral
Neutral rating and $3.90 target maintained.
Read MoreBroker News
SUN – Morgans rates the stock as Hold
The Hold rating is unchanged and the target rises to $12.85 from $11.66.
Read MoreWGX – Macquarie rates the stock as Outperform
As a result of lifting long-term cost forecasts at all three operations the broker lowers the target to $2.30 from $2.50. Outperform maintained.
Read MoreCIP – Morgans rates the stock as Hold
Morgans retains is Hold rating and lifts its target price to $3.87 from $3.71.
Read MoreORI – Credit Suisse rates the stock as Outperform
The broker believes the market is underestimating the likely strength of a recovery in profit from the second half. Outperform maintained. Target is reduced to $15.66 from $16.47.
Read MoreREA – Morgans rates the stock as Hold
Morgans lifts its target price to $160.4 from $139.4.
Read MorePNI – Morgans rates the stock as Hold
Morgans lifts its target price to $14.48 from $11.85 though lowers its rating to Hold from Add, as the stock is now trading in-line with valuation.
Read MoreRMS – Morgans rates the stock as Add
The broker maintains its Add rating and lowers its target price to $2.05 from $2.24.
Read MorePNI – Macquarie rates the stock as Outperform
Macquarie retains an Outperform rating and raises the target to $15.33 from $12.28.
Read MoreWPL – UBS rates the stock as Buy
The broker’s Buy rating and $26.10 target is maintained, as the company trades with an implied oil price of $54/bbl versus spot of $72/bbl.
Read MoreLNK – Credit Suisse rates the stock as Outperform
Credit Suisse believes value has emerged and raises the target to $5.55 from $5.40, while upgrading to Outperform from Neutral.
Read MoreBWP – UBS rates the stock as Sell
UBS retains its Sell rating and $3.86 target price.
Read MoreCWN – Credit Suisse rates the stock as Neutral
Neutral rating and $10.10 target maintained.
Read MoreFCT – Morgans rates the stock as Add
The broker retains its Speculative Buy rating and $0.16 target price, after making no changes to medium-term forecasts.
Read MoreOSH – UBS rates the stock as Buy
The broker believes the market is currently undervaluing the Oil Search portfolio, although recognises the growth projects are more likely to achieve full value as part of a merged business. Buy rating and $4.65 target maintained.
Read More29M – Macquarie rates the stock as Outperform
Macquarie initiates coverage with an Outperform rating and $3 target and believes improved production results will be the key catalyst over 2021.
Read MoreCCP – Macquarie rates the stock as Outperform
The broker retains an Outperform rating and reduces the target to $33.10 from $34.80.
Read MoreCOF – Morgans rates the stock as Hold
The broker retains its Hold rating and edges up its price target to $2.50 from $2.49.
Read MoreJHG – Macquarie rates the stock as Outperform
Outperform maintained. Target rises to $63.50 from $56.00.
Read MoreORG – UBS rates the stock as Buy
UBS lowers its price target to $4.75 from $5.15 and retains its Buy rating.
Read MoreRCW – Morgans rates the stock as Hold
Morgans retains its Hold rating and $0.39 target price after Rightcrowd’s fourth quarter annual recurring revenue (ARR) doubled year-on-year.
Read MoreBUB – Citi rates the stock as Sell
Citi retains its Sell rating and lowers its target price to $0.33 from $0.35.
Read MoreSDF – Credit Suisse rates the stock as Outperform
The broker continues to envisage upside risk from organic tailwinds, notwithstanding some cost catch up in the fourth quarter. Outperform rating and $4.60 target maintained.
Read MoreNAB – Morgans rates the stock as Add
Morgans upgrades its rating to Add from Hold in light of recent share price weakness, and retains its $27.50 target price.
Read MoreALQ – UBS rates the stock as Neutral
UBS retains a Neutral rating and raises the target to $13.00 from $12.25.
Read MoreREA – Credit Suisse rates the stock as Neutral
Neutral maintained. Target rises to $152 from $148.
Read MoreAPE – Morgans rates the stock as Add
Morgans lifts its EPS forecasts for FY21-FY23 by 10%, 20% and 20%, respectively, and raises its price target for Eagers Automotive to $19.20 from $1.39.
Read MoreOSH – Credit Suisse rates the stock as Neutral
The broker maintains a Neutral rating, cutting its target to $3.82 from $3.86.
Read MoreAIM – Morgans rates the stock as Add
Morgans retains it Add rating and lifts its target price to $1.44 from $1.38, after increasing FY21 and FY22 EPS forecasts by around 5%.
Read MoreCHL – Morgans rates the stock as Add
Morgans initiates coverage on Camplify Holdings with an Add recommendation, and notes shares are trading at an around -40% discount to the broker’s target price of $1.88.
Read MoreNWH – Macquarie rates the stock as Outperform
Target is raised to $2.15 from $2.10 and an Outperform rating is maintained.
Read MoreXRO – Macquarie rates the stock as Underperform
The broker reviews its current multiples and finds it hard to justify the current valuation, downgrading to Underperform from Neutral. Target is $130.
Read MoreNEC – UBS rates the stock as Buy
Nine Entertainment’s rating is upgraded to Buy from Neutral and the target is raised to $3.10 from $3.00.
Read MorePTB – Morgans rates the stock as Add
Morgans lifts normalised FY21 EPS forecast by 2% and maintains its $0.93 target price.
Read MoreIAG – UBS rates the stock as Buy
UBS retains its Buy rating and lowers its target price to $5.65 from $5.80.
Read MoreNWH – UBS rates the stock as Buy
UBS transfers coverage to another analyst, retaining a Buy rating and reducing the target to $2.37 from $3.00.
Read MorePPT – Morgans rates the stock as Add
The broker maintains its Add rating and lifts its target to $42.21 from $41.63.
Read MoreASX – Macquarie rates the stock as Outperform
Given greater confidence in the growth outlook, the broker upgrades to Ourtperform from Neutral. Target rises to $94.00 from $66.50.
Read MoreEVN – Morgans rates the stock as Hold
Morgans maintains its Hold rating, and reduces its price target to $4.34 from $4.49, as the broker awaits further detail on the Mungari expansion.
Read MoreIAG – Morgans rates the stock as Add
Morgans sees value in the group and retains its Add rating while lowering FY21 and FY22 EPS estimates by -8% and -2%. The broker’s price target falls to $5.37 from $5.46.
Read More
